Physician profile
Jonathan Greenleaf
NPI 1568469278
$8,719.28
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2021: $3,041 · 2022: $3,328 · 2023: $103 · 2024: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $5,090.98 | 2019-2024 | |
| Conformis, INC. | $2,022.48 | 2019-2022 | |
| Arthrex, INC. | $739.30 | 2019 | |
| Linvatec Corporation | $352.78 | 2021 | |
| Zimmer Biomet Holdings, INC. | $129.55 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $121.88 | 2024 | Exparel |
| Bioventus LLC | $81.35 | 2019-2024 | Durolane |
| Sanofi-Aventis U.S. LLC | $36.00 | 2019 | |
| Abbott Laboratories | $32.44 | 2022 | |
| Medtronic Vascular, INC. | $30.84 | 2019 | |
| Fidia Pharma USA INC. | $29.38 | 2024 | Triluron |
| Pacira Therapeutics, INC. | $22.26 | 2021 | |
| Avanos Medical | $15.77 | 2019 | |
| Depuy Synthes Sales INC. | $14.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Greenleaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.